1. Home
  2. LIVE vs CGTX Comparison

LIVE vs CGTX Comparison

Compare LIVE & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Live Ventures Incorporated

LIVE

Live Ventures Incorporated

N/A

Current Price

$11.44

Market Cap

30.3M

ML Signal

N/A

Logo Cognition Therapeutics Inc.

CGTX

Cognition Therapeutics Inc.

HOLD

Current Price

$1.73

Market Cap

158.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIVE
CGTX
Founded
1968
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.3M
158.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
LIVE
CGTX
Price
$11.44
$1.73
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$2.88
AVG Volume (30 Days)
6.5K
978.2K
Earning Date
12-11-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.46
N/A
Revenue
$443,794,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$24.90
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.25
$0.22
52 Week High
$25.88
$3.83

Technical Indicators

Market Signals
Indicator
LIVE
CGTX
Relative Strength Index (RSI) 48.67 54.36
Support Level $9.05 $1.58
Resistance Level $12.49 $1.81
Average True Range (ATR) 1.04 0.13
MACD 0.33 0.03
Stochastic Oscillator 69.44 82.30

Price Performance

Historical Comparison
LIVE
CGTX

About LIVE Live Ventures Incorporated

Live Ventures Inc is a holding company for diversified businesses. It is focused on acquiring and operating profitable companies in various industries. The company operates in the business segments of Retail Entertainment which includes direct sales of entertainment and appliance products and services, Flooring Manufacturing, Steel Manufacturing, which includes the sale of steel plates, ground flat stock, and drill rods, and Corporate and Other. It derives key revenue from the Flooring Manufacturing segment which includes the manufacturing of carpets and rugs, yarn products, as well as a reseller of hard surface flooring products. Geographically the activities are carried out throughout the United States.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: